Democritus University of Thrace (DUTH)
Η επίδραση της λορνοξικάμης στην φλεγμονώδη αντίδραση των πνευμόνων μετά από επεμβάσεις καρδιάς υπό εξωσωματική κυκλοφορία
Abstract
dc:descriptionAim: The establishment of Extracorporeal Circulation (EC) significantly contributed to improvement of cardiac surgery, but this is accompanied by harmful side-effects. The most important of them is systemic inflammatory response syndrome. Many efforts have been undertaken to minimize this problem but unfortunately without satisfied solution to date. Lornoxicam is a non steroid anti-inflammatory drug which temporally inhibits the cycloxygenase. In this clinical trial we study the effect of lornoxicam in lung inflammatory response after operations for cardiac surgery with cardiopulmonary bypass. Materials and methods: In our study we conclude 14 volunteers patients with ischemic coronary disease undergoing coronary artery bypass grafting with EC. In 7 of them 16mg lornoxicam was administered iv before the anesthesia induction and before the connection in heart-lung machine. In control group (7 patients) we administered the same amount of normal saline. Both groups are equal regarding pro-operative and intra-operative parameters. The inflammatory markers were calculated by Elisa method. We measured the levels of cytokines (IL-6, IL-8, TNF-a), adhesion molecules (ICAM-1, e-Selectin, p-Selectin) and matrix metaloproteinase-3 (MMP-3) just after anesthesia induction, before and after cardiopulmonary bypass, just after the patients administration in ICU and after 8 and 24 h. In all patients we estimated the lung’s inflammatory reaction with lung biopsy taken at the begging and at the end of the operation. We calculated hemodynamics parameters: Cardiac Index (CI), Systemic Vascular Resistance Index (SVRI), Pulmonary Vascular Resistance Index (PVRI), Left Ventricular Stroke Work Index (LVSWI), Right Ventricular Stroke Work Index (RVSWI), and the Pulmonary arterial pressure, and respiratory parameters too: alveolo-arterial oxygen difference D(A-a), intrapulmonary shunt (Qs/Qt) and pulmonary Compliance.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsakiridis, Kosmas
- Τσακιρίδης, Κοσμάς
Subjects
dc:subject × 20- Λορνοξικάμη
- Σύνδρομο συστηματικής φλεγμονώδους αντίδρασης
- Χειρουργική καρδιάς
- Εξωσωματική κυκλοφορία
- ΜΣΑΦ
- Πνεύμονες
- Μεσολαβητές φλεγμονής
- Μόρια προσκόλλησης
- Lornoxicam
- SIRS
- Cardiac surgery
- Cardiopulmonary bypass
- NSAID
- Lungs
- Inflammatory mediators
- Adhession molecules
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17600